Clopidogrel
Clopidogrel is a pharmaceutical drug with 407 clinical trials. Currently 30 active trials ongoing. Historical success rate of 91.8%.
Success Metrics
Based on 270 completed trials
Phase Distribution
Phase Distribution
60
Early Stage
54
Mid Stage
245
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
89.1%
270 of 303 finished
10.9%
33 ended early
30
trials recruiting
407
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
CES1 Carriers in the PAPI Study
Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
CES1 Crossover Trial of Clopidogrel and Ticagrelor
Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization
A Pilot Study to Investigate Platelet Reactivity in Patients With Elevated Lipoprotein(a) and Its Response to Antiplatelet Therapy
Clinical Trials (407)
CES1 Carriers in the PAPI Study
Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
CES1 Crossover Trial of Clopidogrel and Ticagrelor
Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization
A Pilot Study to Investigate Platelet Reactivity in Patients With Elevated Lipoprotein(a) and Its Response to Antiplatelet Therapy
Use and Costs of P2Y12 Inhibitors After Acute Myocardial Infarction
Multicentric Study on Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)
The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate)and Plavix® in Healthy Participants
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic Stroke
Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel
Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI
TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement
Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease
Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.
AERIAL Trial: Antiplatelet Therapy in Heart Transplantation
Clopidogrel Versus Cilostazol on Vessels
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)
The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis
Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 407